Abstract
Any medical or surgical therapy for male infertility is useless in the following cases: globozoospermia, aged female partner and polycystic ovary syndrome, Y microdeletions, high follicle-stimulating hormone (FSH), and unexplained male infertility; thus ART should be immediately started. When there is no identifiable cause of infertility and the results of the semen analysis are normal, the patients are categorized as having unexplained male infertility. Genetic defects may be involved in the cause of infertility. Thus ART might be the only way to conceive (see Chap. 10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parlamento della repubblica Italiana. Legge 19 febbraio 2004, n. 40, “Norme in materia di procreazione medicalmente assistita”. Gazzetta Ufficiale n. 45 del 24 febbraio 2004
Schirren C, Holstein A, Schirren C (1971) Uber die Morphogenese rundkopfiger Spermatozoen des Menschen. Andrologie 3:117–125
Kilani ZM, Shaban MA, Ghunaim SD, Keilani SS, Dakkak AI (1998) Triplet pregnancy and delivery after intracytoplasmic injection of round-headed spermatozoa. Hum Reprod 13:2177–2179
Dam AH, Koscinski I, Kremer JA, Moutou C, Jaeger AS, Oudakker AR, Tournaye H, Charlet N, Lagier-Tourenne C, van Bokhoven H (2007) Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet 81:813–820
Dam AH, Ramos L, Dijkman HB, Woestenenk R, Robben H, van den Hoven L, Kremer JA (2011) Morphology of partial globozoospermia. J Androl 32:199–206
Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG (2009) Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol 7:101–108
Barad DH, Weghofer A, Gleicher N (2009) Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril 91:1553–1555
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC (2010) Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16:113–130
Sunderam S, Kissin DM, Flowers L, Anderson JE, Folger SG, Jamieson DJ, Barfield WD, Centers for Disease Control and Prevention (CDC) (2012) Assisted reproductive technology surveillance–United States, 2009. MMWR Surveill Summ 61:1–23
Schlegel PN (2012) Contemporary issues in varicocele management. Curr Opin Urol 22:487–488
de Resende LO, Vireque AA, Santana LF, Moreno DA, De Sá Rosa e Silva AC, Ferriani RA, Scrideli CA, Reis RM (2012) Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation. J Assist Reprod Genet 29:1057–1065
Choi DK, Gong IH, Hwang JH, Oh JJ, Hong JY (2013) Detection of Y chromosome microdeletion is valuable in the treatment of patients with nonobstructive azoospermia and oligoasthenoteratozoospermia: sperm retrieval rate and birth rate. Korean J Urol 54:111–116
Sagnak L, Ersoy H, Ozok U, Eraslan A, Yararbas K, Goktug G, Tukun A (2010) The significance of Y chromosome microdeletion analysis in subfertile men with clinical varicocele. Arch Med Sci 6:382–387
Matzuk MM, Lamb DJ (2008) The biology of infertility: research advances and clinical challenges. Nat Med 14:1197–1213
Comhaire F, Decleer W (2011) Quantifying the effectiveness and cost-efficiency of food supplementation with antioxidants for male infertility. Reprod Biomed Online 23:361–362
Comhaire F, Decleer W (2012) Comparing the effectiveness of infertility treatments by numbers needed to treat (NNT). Andrologia 44:401–404
Dafopoulos K, Griesinger G, Schultze-Mosgau A, Orief Y, Schopper B (2005) Factors affecting outcome after ICSI with spermatozoa retrieved from cryopreserved testicular tissue in non obstructive azoospermia. Reprod Biomed Online 10:455–460
de Croo I, van der Elst J, Everaert K, de Sutter P, Dhont M (2000) Fertilization, pregnancy and embryo implantation rates after ICSI in cases of obstructive and non-obstructive azoospermia. Hum Reprod 15:1383–1388
Zitzmann M, Nordhoff V, von Schonfeld V, Nordsiek-Mengede A, Kliesch S (2006) Elevated follicle stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue. Fertil Steril 86:339–347
Cavallini G, Cristina Magli M, Crippa A, Resta S, Vitali G, Pia Ferraretti A, Gianaroli L (2011) The number of spermatozoa collected with testicular sperm extraction is a novel predictor of intracytoplasmic sperm injection outcome in non-obstructive azoospermic patients. Asian J Androl 13:312–316
Anawalt BD (2013) Approach to male infertility and induction of spermatogenesis. J Clin Endocrinol Metab 98:3532–3542
Beretta G, Fino E, Sibilio L, Dilena M (2005) Menotropin (hMG) and idiopathic oligoastenoteratozoospermia (OAT): effects on seminal fluid parameters and on results in ICSI cycles. Arch Ital Urol Androl 77:18–21
Weedin JW, Khera M, Lipshultz LI (2010) Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol 183:2309–2315
Cavallini G, Magli MC, Crippa A, Ferraretti AP, Gianaroli L (2012) Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. Asian J Androl 14:591–598
McIntyre M, Hsieh TC, Lipshultz L (2012) Varicocele repair in the era of modern assisted reproductive techniques. Curr Opin Urol 22:517–520
Bonduelle M, Liebaers I, Deketelaere V, Derde VM, Camus M et al (2002) Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod 17:671–694
Hindryckx A, Peeraer K, Debrock S, Legius E, de Zegher F (2010) Has the prevalence of congenital abnormalities after intracytoplasmic sperm injection increased? The Leuven data 1994–2000 and a review of the literature. Gynecol Obstet Invest 29:11–22
El Khattabi L, Dupont C, Sermondade N, Hugues JN, Poncelet C, Porcher R, Cedrin-Durnerin I, Lévy R, Sifer C (2013) Is intracytoplasmic morphologically selected sperm injection effective in patients with infertility related to teratozoospermia or repeated implantation failure? Fertil Steril 100:62–68
Gianaroli L, Magli MC, Ferraretti AP, Crippa A, Lappi M, Capitani S, Baccetti B (2010) Birefringence characteristics in sperm heads allow for the selection of reacted spermatozoa for intracytoplasmic sperm injection. Fertil Steril 93:807–813
Cavallini G, Ferraretti AP, Gianaroli L, Biagiotti G, Vitali G (2004) Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl 25:761–770
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cavallini, G., Beretta, G. (2015). The Role of the Andrologist in Assisted Reproduction. In: Cavallini, G., Beretta, G. (eds) Clinical Management of Male Infertility. Springer, Cham. https://doi.org/10.1007/978-3-319-08503-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-08503-6_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08502-9
Online ISBN: 978-3-319-08503-6
eBook Packages: MedicineMedicine (R0)